Document is current

Article History

Accepted: 14 June 2025

First Online: 21 June 2025

Declarations

:

: This study was funded by Johnson & Johnson.

: Danny Nguyen reports: honoraria/advisory role: Novartis and Takeda; stock or other ownership interests: Intuitive Surgical and Teladoc. Edgardo S. Santos reports: advisory board or panel/consultant: AZ, AbbVie, Regeneron, Novartis, Johnson & Johnson, BI, Novocure, and EMD Serono; speaker bureau: Amgen, AZ, BMS, BI, Lilly, Pharmacosmos, Jazz Pharmaceuticals, Johnson & Johnson, Merck, Pfizer, Regeneron, Coherus, Takeda, and Novocure.

: The MARIPOSA and COCOON studies were conducted in accordance with the principles of the Declaration of Helsinki and the Good Clinical Guidelines of the International Council for Harmonisation. The protocol and amendments were approved by the institutional review board at each study site.

: All patients provided written informed consent for these studies.

: Not applicable.

: The data sharing policy of Johnson & Johnson is available at . As noted on this site, requests for access to the study data can be submitted through the Yale Open Data Access (YODA) Project site at .

: Not applicable.

: DN: conceptualization; data curation; writing (original draft); and writing (review and editing). ESS: conceptualization; data curation; writing (original draft); and writing (review and editing).